Cargando…

Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes

Type 2 diabetes is a leading cause of chronic kidney disease worldwide and continues to increase in prevalence. This in turn has significant implications for healthcare provision and the economy. In recent years there have been multiple advances in the glucose-lowering agents available for the treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Bhailís, Áine M., Azmi, Shazli, Kalra, Philip A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Diabetic Kidney Disease: Pathogenesis and Therapeutic Targets
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165820/ https://www.ncbi.nlm.nih.gov/pubmed/34104399 http://dx.doi.org/10.1177/20420188211020664

Ejemplares similares

Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future
por: Mallik, Ritwika, et al.
Publicado: (2022)

Examining the factors contributing to the association between non-albuminuric CKD and a low rate of kidney function decline in diabetes
por: Buyadaa, Oyunchimeg, et al.
Publicado: (2022)

The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice
por: von Scholten, Bernt Johan, et al.
Publicado: (2022)

Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China
por: Liu, Yazhuo, et al.
Publicado: (2022)

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence?
por: Ujjawal, Aditi, et al.
Publicado: (2022)

Diabetic nephropathy as the cause of end-stage kidney disease reported on the medical evidence form CMS2728 at a single center
por: Yuan, Christina M., et al.
Publicado: (2017)

Sodium-glucose cotransporter 2 inhibitors for diabetic kidney disease: a primer for deprescribing
por: Li, Jiahua, et al.
Publicado: (2019)

Specific impact of past and new major cardiovascular events on acute kidney injury and end-stage renal disease risks in diabetes: a dynamic view
por: Pinier, Cédric, et al.
Publicado: (2019)

The large spectrum of renal disease in diabetic patients
por: Bermejo, Sheila, et al.
Publicado: (2017)

Diabetes mellitus: a single cardiorenal syndrome umbrella
por: Rodríguez, Eva, et al.
Publicado: (2019)

The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern?
por: Sarafidis, Pantelis A, et al.
Publicado: (2019)

Chronic kidney disease: Definition, updated epidemiology, staging, and mechanisms of increased cardiovascular risk
por: Wilson, Scott, et al.
Publicado: (2021)

Newer potential pharmacological targets for autism spectrum disorder
por: Jain, R. Ashish, et al.
Publicado: (2019)

Autosomal Dominant Polycystic Kidney Disease Is a Risk Factor for Posttransplantation Diabetes Mellitus: An Updated Systematic Review and Meta-analysis
por: Culliford, Alice, et al.
Publicado: (2020)

Effect of Intermittent Fasting on Glycaemic Control in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Sharma, Suresh K, et al.
Publicado: (2023)

Diabetes, deafness and renal disease
por: Godinho, Iolanda, et al.
Publicado: (2017)

Long-term outcome in inherited nephrogenic diabetes insipidus
por: Sharma, Sonia, et al.
Publicado: (2018)

Incident chronic kidney disease: trends in management and outcomes
por: Perkins, Robert M., et al.
Publicado: (2016)

Case Report: Absence of Clinically Significant Recurrent Diabetic Kidney Disease on Postmortem Biopsy 32 Years After Kidney Transplantation for Type 1 Diabetes
por: Nicholl, David D. M., et al.
Publicado: (2021)

Defining Disease Progression and Drug Durability in Type 2 Diabetes Mellitus
por: Kalra, Sanjay, et al.
Publicado: (2019)

Kidney Donors With Diabetes: Renal Biopsy Findings at Time of Transplantation and Their Significance
por: Truong, Luan D., et al.
Publicado: (2019)

Early Treatment With Olmesartan Prevents Juxtamedullary Glomerular Podocyte Injury and the Onset of Microalbuminuria in Type 2 Diabetic Rats
por: Sofue, Tadashi, et al.
Publicado: (2012)

Glycaemic control in type 2 diabetic patients with chronic kidney disease: the impacts on enzymatic antioxidants and soluble RAGE
por: Wong, Foo Nian, et al.
Publicado: (2018)

Chronic kidney disease in children
por: Becherucci, Francesca, et al.
Publicado: (2016)

Potential and pitfalls in the genetic diagnosis of kidney diseases
por: Kesselheim, Anne, et al.
Publicado: (2017)

Electronic patient-reported outcomes in clinical kidney practice (ePRO Kidney): a process evaluation of educational support for clinicians
por: Schick-Makaroff, Kara, et al.
Publicado: (2023)

Consequences of morbid obesity on the kidney. Where are we going?
por: Navarro Díaz, Maruja
Publicado: (2016)

HIV and kidney diseases: 35 years of history and consequences
por: Campos, Pedro, et al.
Publicado: (2016)

The Use of GLP1R Agonists for the Treatment of Type 2 Diabetes in Kidney Transplant Recipients
por: Kukla, Aleksandra, et al.
Publicado: (2020)

How Should We Think About the Role of the Brain in Glucose Homeostasis and Diabetes?
por: Deem, Jennifer D., et al.
Publicado: (2017)

Chronic kidney disease hotspots in developing countries in South Asia
por: Abraham, Georgi, et al.
Publicado: (2016)

The dynamics of the general practitioner-nephrologist collaboration for the management of patients with chronic kidney disease before and after dialysis initiation: a mixed-methods study
por: Raffray, Maxime, et al.
Publicado: (2022)

Effect of Early Steroid Withdrawal on Posttransplant Diabetes Among Kidney Transplant Recipients Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021)

Development and Validation of a New Score to Assess the Risk of Posttransplantation Diabetes Mellitus in Kidney Transplant Recipients
por: Serna-Higuita, Lina Maria, et al.
Publicado: (2023)

Impact of routine reporting of estimated glomerular filtration rate using the European Kidney Function Consortium and Chronic Kidney Disease Epidemiology Collaboration equations in a Western Australian community population
por: Napier, Kathryn, et al.
Publicado: (2022)

Patient kidney disease knowledge remains inadequate with standard nephrology outpatient care
por: Gray, Nicholas A., et al.
Publicado: (2016)

Safety concerns about intravenous iron therapy in patients with chronic kidney disease
por: Del Vecchio, Lucia, et al.
Publicado: (2016)

Noninvasive markers of arterial stiffness and renal outcomes in patients with chronic kidney disease
por: Guo, Xinru, et al.
Publicado: (2021)

Chronic kidney disease in public renal practices in Queensland, Australia, 2011–2018
por: Hoy, Wendy E., et al.
Publicado: (2022)

High prevalence of chronic kidney disease in a semi-urban population of Western India
por: Trivedi, Hargovind, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vp4vejdhe0g1ga2ji9rnn6ah8v